Bank Of New York Mellon Corp Mannkind Corp Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.02 - $5.37 $2.83 Million - $5.04 Million	937,933 New	937,933 $4.94 Million
Q3 2022 Nov 14, 2022	BUY	$2.99 - $4.35 $188,426 - $274,132	63,019 Added 8.02%	848,744 $2.62 Million
Q2 2022 Aug 15, 2022	SELL	$2.67 - $4.77 $196,717 - $351,439	-73,677 Reduced 8.57%	785,725 $2.99 Million
Q1 2022 May 11, 2022	SELL	$2.62 - $4.45 $26,435 - $44,900	-10,090 Reduced 1.16%	859,402 $3.16 Million
Q4 2021 Feb 11, 2022	SELL	$4.05 - $5.37 $17,726 - $23,504	-4,377 Reduced 0.5%	869,492 $3.8 Million
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $258,206 - $363,745	66,377 Added 8.22%	873,869 $3.8 Million
Q2 2021 Aug 11, 2021	BUY	$3.61 - $5.45 $505,017 - $762,422	139,894 Added 20.95%	807,492 $4.4 Million
Q1 2021 May 13, 2021	SELL	$3.14 - $6.14 $62,043 - $121,320	-19,759 Reduced 2.87%	667,598 $2.62 Million
Q4 2020 Feb 09, 2021	BUY	$1.79 - $4.04 $49,135 - $110,898	27,450 Added 4.16%	687,357 $2.15 Million
Q3 2020 Nov 12, 2020	SELL	$1.56 - $2.08 $4,385 - $5,846	-2,811 Reduced 0.42%	659,907 $1.24 Million
Q2 2020 Aug 12, 2020	BUY	$0.94 - $2.21 $110,454 - $259,686	117,505 Added 21.55%	662,718 $1.16 Million
Q1 2020 May 06, 2020	BUY	$0.84 - $1.76 $22,239 - $46,597	26,476 Added 5.1%	545,213 $561,000
Q4 2019 Feb 14, 2020	BUY	$1.14 - $1.49 $10,016 - $13,091	8,786 Added 1.72%	518,737 $669,000
Q3 2019 Nov 07, 2019	BUY	$1.04 - $1.44 $16,136 - $22,343	15,516 Added 3.14%	509,951 $637,000
Q2 2019 Aug 12, 2019	BUY	$1.09 - $1.88 $21,717 - $37,457	19,924 Added 4.2%	494,435 $568,000
Q1 2019 May 14, 2019	BUY	$1.14 - $2.25 $46,987 - $92,738	41,217 Added 9.51%	474,511 $935,000
Q4 2018 Feb 11, 2019	BUY	$1.02 - $2.05 $36,435 - $73,228	35,721 Added 8.98%	433,294 $459,000
Q3 2018 Nov 09, 2018	BUY	$1.01 - $2.19 $9,289 - $20,143	9,198 Added 2.37%	397,573 $0
Q2 2018 Aug 06, 2018	BUY	$1.59 - $2.38 $488,885 - $731,790	307,475 Added 380.07%	388,375 $738,000
Q1 2018 May 15, 2018	BUY	$2.28 - $3.8 $34,359 - $57,266	15,070 Added 22.89%	80,900 $185,000
Q4 2017 Feb 09, 2018	BUY	$2.28 - $6.71 $150,092 - $441,719	65,830	65,830 $153,000

Others Institutions Holding MNKD

# of Institutions

245

Shares Held

148M

Call Options Held

1.62M

Put Options Held

802K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account